Table 2.
RNA binding proteins and predicted effects on atherogenicity.
| RNA-binding protein | Abbreviation | Effect on TNFα mRNA levels | Mechanism | Predicted Atherogenecity |
|---|---|---|---|---|
| Human antigen R | HuR | Increase105,106 | Stabilizes RNA105,106 | Pro-atherogenic |
| Tristetraprolin | TTP | Decrease107 | Destabilizes RNA107 | Anti-atherogenic |
| ARE/poly(U)-binding/degradation factor | AUF-1 | Decrease108 | Destabilizes RNA108 | Anti-atherogenic |
| T-cell-restricted intracellular antigen-1 | TIA-1 | Decrease109 | Inhibits translation110 | Anti-atherogenic |
| TIA-1-related protein | TIAR | Decrease109 | Inhibits translation110 | Anti-atherogenic |
| CUG triplet repeat RNA binding protein 1 | CUGBP1 | Decrease113 | Destabilizes RNA113,114 | Anti-atherogenic |